Treatment of multiple sclerosis with interferon beta-1b - Reply

Treatment of multiple sclerosis with interferon beta-1b - Reply

Bibliographic Details
Main Authors:	Sibley, W, Ebers, G, Lublin, F, Paty, D, Reder, A
Format:	Journal article
Published:	1997

Similar Items

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY
by: Sibley, W, et al.
Published: (1994)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.
by: Petkau, A, et al.
Published: (2004)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis
by: Petkau, A, et al.
Published: (2004)

INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL
by: Duquette, P, et al.
Published: (1995)

Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS.
by: Rice, G, et al.
Published: (1999)

Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years
by: Duquette, P, et al.
Published: (1996)

Treatment of multiple sclerosis with interferon beta-1 b.
by: Abdul-Ahad, A, et al.
Published: (1997)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
by: Filippini, G, et al.
Published: (2003)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
by: Filippini, G, et al.
Published: (2003)

16-year long-term follow-up of interferon beta-1b treatment in patients with multiple sclerosis
by: Ebers, G, et al.
Published: (2005)

Interferon beta treatment of multiple sclerosis.
by: Markovitz, D
Published: (1994)

MULTIPLE-SCLEROSIS IN TWINS - REPLY
by: Ebers, G
Published: (1987)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
by: Damiano Paolicelli, et al.
Published: (2009-07-01)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
by: Ebers, G, et al.
Published: (1997)

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
by: Ebers, G, et al.
Published: (2009)

Beta-interferons in multiple sclerosis
by: Aggarwal Sourabh, et al.
Published: (2010-01-01)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
by: Ebers, G, et al.
Published: (1998)

PAIN IN MULTIPLE-SCLEROSIS - REPLY
by: Moulin, D, et al.
Published: (1989)

Studies in familial multiple sclerosis.
by: Ebers, G, et al.
Published: (1980)

STUDIES IN FAMILIAL MULTIPLE-SCLEROSIS
by: Ebers, G, et al.
Published: (1980)

Systemic interferon alfa in multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1989)

CLINICAL PROGNOSTIC MARKERS IN MULTIPLE-SCLEROSIS
by: Paty, D, et al.
Published: (1979)

PHARMACOGENETICS OF INTERFERON BETA IN MULTIPLE SCLEROSIS
by: Mohamed Rayen Ganouni, et al.
Published: (2023-10-01)

Neuroimaging in multiple sclerosis.
by: Noseworthy, J, et al.
Published: (1984)

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives
by: Mark S. Freedman, et al.
Published: (2024-01-01)

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.
by: Paty, D, et al.
Published: (1993)

The final results of the interferon beta-1b 16-year long-term follow-up study
by: Ebers, G, et al.
Published: (2006)

PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
by: Reuss R
Published: (2013-05-01)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
by: Castrop F, et al.
Published: (2013-09-01)

MRI ASANOUTCOMEIN MULTIPLE SCLEROSIS CLINICAL TRIALS Reply
by: Ebers, G, et al.
Published: (2009)

MARKERS AND PROGNOSIS IN MULTIPLE-SCLEROSIS
by: Noseworthy, J, et al.
Published: (1983)

ALKALINE ISOELECTRIC-FOCUSING IN POLYACRYLAMIDE-GEL OF CEREBROSPINAL-FLUID IN MULTIPLE-SCLEROSIS
by: Ebers, G, et al.
Published: (1979)

Alkaline isoelectric focusing in polyacrylamide gel of cerebrospinal fluid in multiple sclerosis.
by: Ebers, G, et al.
Published: (1979)

Percutaneous trigeminal rhizotomy. Treatment of trigeminal neuralgia secondary to multiple sclerosis.
by: Brett, D, et al.
Published: (1982)

The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes
by: Reder, A, et al.
Published: (2008)

SPINAL-CORD SWELLING IN MULTIPLE-SCLEROSIS
by: Feasby, T, et al.
Published: (1980)

Spinal cord swelling in multiple sclerosis.
by: Feasby, T, et al.
Published: (1981)

Interferon beta: Medication which started the revolution in the treatment of multiple sclerosis
by: Ivanović Jovana, et al.
Published: (2019-01-01)

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients
by: De Caro Maria, et al.
Published: (2006-12-01)

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
by: Cocco E, et al.
Published: (2015-05-01)